219 related articles for article (PubMed ID: 11729830)
1. HLA-A, B, C antigens in pulmonary sarcoidosis in Polish population.
Dubaniewicz A; Szczerkowska Z
Arch Immunol Ther Exp (Warsz); 1999; 47(1):55-9. PubMed ID: 11729830
[TBL] [Abstract][Full Text] [Related]
2. HLA-DR antigens in patients with pulmonary tuberculosis in northern Poland. Preliminary report.
Dubaniewicz A
Arch Immunol Ther Exp (Warsz); 2000; 48(1):47-50. PubMed ID: 10722232
[TBL] [Abstract][Full Text] [Related]
3. HLA association with sarcoidosis and diffuse interstitial pulmonary fibrosis.
Mahbubani V; Trikannad VS; Sainani GS
J Assoc Physicians India; 1995 Jan; 43(1):28-9. PubMed ID: 9282635
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of HLA class I antigens in pulmonary sarcoidosis and tuberculosis in the same ethnic group.
Dubaniewicz A; Szczerkowska Z; Hoppe A
Mayo Clin Proc; 2003 Apr; 78(4):436-42. PubMed ID: 12683696
[TBL] [Abstract][Full Text] [Related]
5. [HLA histocompatibility antigens in patients with aortic valve defects].
Waszyrowski T; Zebrowski A; Krzemińska-Pakuła M; Miś J; Kaczmarek A
Kardiol Pol; 1991; 35(7):27-30. PubMed ID: 1942751
[TBL] [Abstract][Full Text] [Related]
6. [Human leukocyte antigen (HLA) complex and anti-thyroidal antibodies in Graves' disease].
Lacka K; Kordel M; Gembicki M
Pol Tyg Lek; 1989 Feb 13-20; 44(7-8):179-81. PubMed ID: 2682567
[TBL] [Abstract][Full Text] [Related]
7. HLA class I antigens in families with coeliac disease.
Kedzierska A; Turowski G
Med Sci Monit; 2000; 6(5):957-63. PubMed ID: 11208438
[TBL] [Abstract][Full Text] [Related]
8. HLA antigens and susceptibility to myasthenia gravis.
Matej H; Nowakowska B; Kałamarz M; Paradowski B; Podemski R; Brzecki A
Arch Immunol Ther Exp (Warsz); 1987; 35(6):795-801. PubMed ID: 3508039
[TBL] [Abstract][Full Text] [Related]
9. HLA antigens in Indian population with non-specific aortoarteritis.
Kumar R; Vaidya MC; Kailash S
Indian Heart J; 1990; 42(2):85-7. PubMed ID: 2081614
[TBL] [Abstract][Full Text] [Related]
10. [Association between Class I HLA alleles and HBs antigen carrier status among blood donors in Senegal].
Dieye A; Obami-Itou V; Barry MF; Raphenon G; Thiam A; Ndiaye R; Ndiaye M; Diaw ML; Diakhate L
Dakar Med; 1999; 44(2):166-70. PubMed ID: 11957279
[TBL] [Abstract][Full Text] [Related]
11. HLA antigens and primary osteoarthritis of the hand.
Merlotti D; Santacroce C; Gennari L; Geraci S; Acquafredda V; Conti T; Bargagli G; Canto ND; Biagi F; Gennari C; Giordano N
J Rheumatol; 2003 Jun; 30(6):1298-304. PubMed ID: 12784406
[TBL] [Abstract][Full Text] [Related]
12. [Incidence of antigen expression for HLA antigens A,B,C and DR in patients with atopic diseases in Poland].
Kruszewski J; Kłos M; Nowak J; Wasek Z
Pol Tyg Lek; 1990 Oct 15-29; 45(42-44):851-4. PubMed ID: 2098731
[TBL] [Abstract][Full Text] [Related]
13. HLA antigens in primary fibromyalgia syndrome.
Hørven S; Stiles TC; Holst A; Moen T
J Rheumatol; 1992 Aug; 19(8):1269-70. PubMed ID: 1404164
[TBL] [Abstract][Full Text] [Related]
14. HLA-A and -B phenotypes associated with tuberculosis in population from north-eastern Romania.
Vasilca V; Oana R; Munteanu D; Zugun F; Constantinescu D; Carasevici E
Roum Arch Microbiol Immunol; 2004; 63(3-4):209-21. PubMed ID: 17240790
[TBL] [Abstract][Full Text] [Related]
15. HLA class I and class II frequencies in patients with sarcoidosis from Croatia: role of HLA-B8, -DRB1*0301, and -DQB1*0201 haplotype in clinical variations of the disease.
Grubić Z; Zunec R; Peros-Golubicić T; Tekavec-Trkanjec J; Martinez N; Alilović M; Smojver-Jezek S; Kerhin-Brkljacić V
Tissue Antigens; 2007 Oct; 70(4):301-6. PubMed ID: 17767551
[TBL] [Abstract][Full Text] [Related]
16. [Class I and II antigens and levels of IgG antibodies in patients with infiltrative tuberculosis of the lungs].
Nikolaian LT; Karapetian ET; Pospelov LE
Probl Tuberk; 1989; (3):49-51. PubMed ID: 2786199
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of the distribution of class I HLA-antigens in patients with systemic scleroderma with regard to features of the clinical course of the disease and therapy with D-penicillamine].
Pevnitskiĭ LA; Guseva NG; Sibiriakova LG; Oskilko TG
Genetika; 1989 Jun; 25(6):1101-7. PubMed ID: 2806895
[TBL] [Abstract][Full Text] [Related]
18. HLA as an immunogenetic risk factor in juvenile chronic arthritis.
Matej H; Kałamarz M; Nowakowska B; Prusek W; Podwysocka M; Wieczorek E; Zahorska Z
Arch Immunol Ther Exp (Warsz); 1987; 35(6):787-94. PubMed ID: 3508038
[TBL] [Abstract][Full Text] [Related]
19. Anti HTLV-I antibodies and HLA phenotypes in the West Indies.
Chavance M; Monplaisir N; Valette I; Schaffar-Deshayes L; Raffoux C
Clin Exp Immunol; 1989 Jul; 77(1):11-4. PubMed ID: 2504518
[TBL] [Abstract][Full Text] [Related]
20. [Are we typing HLA-A, B, and C antigens correctly?].
Májský A
Sb Lek; 1993; 94(2):169-72. PubMed ID: 7992010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
